Preview Mode Links will not work in preview mode


Feb 26, 2021

Autor: Euler Manenti

Ref: SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2018 Nov 9.

Feb 24, 2021

Autor: Carlos Eduardo Barra Couri

Ref: Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2018 Nov 10.

Feb 22, 2021

Autor: Cristiano Barcellos

Ref: Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function. J Steroid Biochem Mol Biol. 2015 Nov;154:254-66.

Feb 19, 2021

Autor: Mônica Gabbay

Ref: Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials. Diabetes Metab Res Rev. 2018 May;34(4):e2983.

Feb 18, 2021

Autor: André Vianna

Ref: International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017 Dec;40(12):1631-1640.